Addus HomeCare Co. (NASDAQ:ADUS) Shares Acquired by Northern Trust Corp

Northern Trust Corp increased its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS) by 3.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 285,872 shares of the company’s stock after purchasing an additional 9,122 shares during the quarter. Northern Trust Corp’s holdings in Addus HomeCare were worth $35,834,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Principal Financial Group Inc. lifted its stake in shares of Addus HomeCare by 17.5% in the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after acquiring an additional 75,409 shares during the period. Cherry Creek Investment Advisors Inc. purchased a new position in Addus HomeCare during the fourth quarter worth about $340,000. Amundi lifted its position in Addus HomeCare by 185.9% in the fourth quarter. Amundi now owns 9,008 shares of the company’s stock valued at $1,139,000 after purchasing an additional 5,857 shares during the period. Barclays PLC boosted its holdings in Addus HomeCare by 204.8% in the 3rd quarter. Barclays PLC now owns 43,470 shares of the company’s stock valued at $5,783,000 after purchasing an additional 29,207 shares in the last quarter. Finally, Nordea Investment Management AB increased its position in Addus HomeCare by 5.0% during the 4th quarter. Nordea Investment Management AB now owns 35,756 shares of the company’s stock worth $4,548,000 after purchasing an additional 1,697 shares during the period. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on ADUS shares. Oppenheimer lifted their price target on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Macquarie boosted their price objective on shares of Addus HomeCare from $129.00 to $133.00 and gave the stock an “outperform” rating in a report on Thursday. Stephens reaffirmed an “overweight” rating and issued a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. JMP Securities reissued a “market outperform” rating and set a $150.00 price target on shares of Addus HomeCare in a research note on Tuesday, April 22nd. Finally, StockNews.com downgraded Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $142.57.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $110.91 on Friday. Addus HomeCare Co. has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The company has a market capitalization of $2.04 billion, a price-to-earnings ratio of 25.38, a PEG ratio of 1.41 and a beta of 0.85. The stock has a fifty day moving average of $98.86 and a two-hundred day moving average of $114.47.

Addus HomeCare (NASDAQ:ADUS) last announced its earnings results on Monday, May 5th. The company reported $1.42 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million during the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm’s revenue for the quarter was up 20.3% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.21 EPS. On average, analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.